{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T17:01:31Z","timestamp":1778173291711,"version":"3.51.4"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"This work was supported by National Nature Scientific Funding of China","award":["No. 81672264, 81871858"],"award-info":[{"award-number":["No. 81672264, 81871858"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s10557-020-07001-0","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T07:02:33Z","timestamp":1591254153000},"page":"467-477","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Research Progress on the Involvement of ANGPTL4 and Loss-of-Function Variants in Lipid Metabolism and Coronary Heart Disease: Is the \u201cPrime Time\u201d of ANGPTL4-Targeted Therapy for Coronary Heart Disease Approaching?"],"prefix":"10.1007","volume":"35","author":[{"given":"Jingmin","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2113-0800","authenticated-orcid":false,"given":"Danyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,4]]},"reference":[{"key":"7001_CR1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cmet.2016.01.005","volume":"23","author":"DJ Rader","year":"2016","unstructured":"Rader DJ. New therapeutic approaches to the treatment of Dyslipidemia. Cell Metab. 2016;23:405\u201312.","journal-title":"Cell Metab"},{"issue":"Suppl 1","key":"7001_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.18.S1.1","volume":"18","author":"PS Jellinger","year":"2012","unstructured":"Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, et al. American Association of Clinical Endocrinologists' guidelines for Management of Dyslipidemia and Prevention of atherosclerosis. Endocr Pract. 2012;18(Suppl 1):1\u201378.","journal-title":"Endocr Pract"},{"key":"7001_CR3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2016.08.018","volume":"253","author":"AL Catapano","year":"2016","unstructured":"Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC\/EAS guidelines for the Management of Dyslipidaemias: the task force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European atherosclerosis society (EAS) developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016;253:281\u2013344.","journal-title":"Atherosclerosis"},{"key":"7001_CR4","doi-asserted-by":"crossref","first-page":"e008740","DOI":"10.1161\/JAHA.118.008740","volume":"7","author":"PP Toth","year":"2018","unstructured":"Toth PP, Granowitz C, Hull M, Liassou D, Anderson A, Philip S. High triglycerides are associated with increased cardiovascular events, medical costs, and resource use: a real-world administrative claims analysis of statin-treated patients with high residual cardiovascular risk. J Am Heart Assoc. 2018;7:e008740.","journal-title":"J Am Heart Assoc"},{"key":"7001_CR5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/VHRM.S104369","volume":"12","author":"PP Toth","year":"2016","unstructured":"Toth PP. Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease. Vasc Health Risk Manag. 2016;12:171\u201383.","journal-title":"Vasc Health Risk Manag"},{"key":"7001_CR6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41:111\u201388.","journal-title":"Eur Heart J"},{"key":"7001_CR7","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.jacc.2014.09.042","volume":"64","author":"RS Rosenson","year":"2014","unstructured":"Rosenson RS, Davidson MH, Hirsh BJ, Kathiresan S, Gaudet D. Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease. J Am Coll Cardiol. 2014;64:2525\u201340.","journal-title":"J Am Coll Cardiol"},{"key":"7001_CR8","first-page":"919","volume":"2014","author":"S Kersten","year":"1841","unstructured":"Kersten S. Physiological regulation of lipoprotein lipase. Biochim Biophys Acta. 1841;2014:919\u201333.","journal-title":"Biochim Biophys Acta"},{"key":"7001_CR9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/MOL.0000000000000290","volume":"27","author":"W Dijk","year":"2016","unstructured":"Dijk W, Kersten S. Regulation of lipid metabolism by angiopoietin-like proteins. Curr Opin Lipidol. 2016;27:249\u201356.","journal-title":"Curr Opin Lipidol"},{"key":"7001_CR10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1701329","volume":"377","author":"MJ Graham","year":"2017","unstructured":"Graham MJ, Lee RG, Brandt TA, Tai LJ, Fu W, Peralta R, et al. Cardiovascular and metabolic effects of ANGPTL3 antisense oligonucleotides. N Engl J Med. 2017;377:222\u201332.","journal-title":"N Engl J Med"},{"key":"7001_CR11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1612790","volume":"377","author":"FE Dewey","year":"2017","unstructured":"Dewey FE, Gusarova V, Dunbar RL, O'Dushlaine C, Schurmann C, Gottesman O, et al. Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease. N Engl J Med. 2017;377:211\u201321.","journal-title":"N Engl J Med"},{"key":"7001_CR12","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1194\/jlr.M054890","volume":"56","author":"V Gusarova","year":"2015","unstructured":"Gusarova V, Alexa CA, Wang Y, Rafique A, Kim JH, Buckler D, et al. ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys. J Lipid Res. 2015;56:1308\u201317.","journal-title":"J Lipid Res"},{"key":"7001_CR13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ng1984","volume":"39","author":"S Romeo","year":"2007","unstructured":"Romeo S, Pennacchio LA, Fu Y, Boerwinkle E, Tybjaerg-Hansen A, Hobbs HH, et al. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet. 2007;39:513\u20136.","journal-title":"Nat Genet"},{"key":"7001_CR14","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.metabol.2008.06.016","volume":"57","author":"AR Folsom","year":"2008","unstructured":"Folsom AR, Peacock JM, Demerath E, Boerwinkle E. Variation in ANGPTL4 and risk of coronary heart disease: the atherosclerosis risk in communities study. Metabolism. 2008;57:1591\u20136.","journal-title":"Metabolism."},{"key":"7001_CR15","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJMoa1510926","volume":"374","author":"FE Dewey","year":"2016","unstructured":"Dewey FE, Gusarova V, O'Dushlaine C, Gottesman O, Trejos J, Hunt C, et al. Inactivating variants in ANGPTL4 and risk of coronary artery disease. N Engl J Med. 2016;374:1123\u201333.","journal-title":"N Engl J Med"},{"key":"7001_CR16","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1507652","volume":"374","author":"G Myocardial Infarction","year":"2016","unstructured":"Myocardial Infarction G, Investigators CAEC, Stitziel NO, Stirrups KE, Masca NG, Erdmann J, et al. Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease. N Engl J Med. 2016;374:1134\u201344.","journal-title":"N Engl J Med"},{"key":"7001_CR17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/10623320600697989","volume":"13","author":"T Morisada","year":"2006","unstructured":"Morisada T, Kubota Y, Urano T, Suda T, Oike Y. Angiopoietins and angiopoietin-like proteins in angiogenesis. Endothelium. 2006;13:71\u20139.","journal-title":"Endothelium."},{"key":"7001_CR18","doi-asserted-by":"crossref","first-page":"15724","DOI":"10.1073\/pnas.0404089101","volume":"101","author":"D Wan","year":"2004","unstructured":"Wan D, Gong Y, Qin W, Zhang P, Li J, Wei L, et al. Large-scale cDNA transfection screening for genes related to cancer development and progression. Proc Natl Acad Sci U S A. 2004;101:15724\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 3","key":"7001_CR19","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1042\/bj3460603","volume":"346","author":"I Kim","year":"2000","unstructured":"Kim I, Kim HG, Kim H, Kim HH, Park SK, Uhm CS, et al. Hepatic expression, synthesis and secretion of a novel fibrinogen\/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem J. 2000;346(Pt 3):603\u201310.","journal-title":"Biochem J"},{"key":"7001_CR20","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.molmed.2019.05.010","volume":"25","author":"B Aryal","year":"2019","unstructured":"Aryal B, Price NL, Suarez Y, Fernandez-Hernando C. ANGPTL4 in metabolic and cardiovascular disease. Trends Mol Med. 2019;25:723\u201334.","journal-title":"Trends Mol Med"},{"key":"7001_CR21","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1074\/jbc.M307583200","volume":"279","author":"H Ge","year":"2004","unstructured":"Ge H, Yang G, Huang L, Motola DL, Pourbahrami T, Li C. Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4. J Biol Chem. 2004;279:2038\u201345.","journal-title":"J Biol Chem"},{"key":"7001_CR22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1586\/epr.12.12","volume":"9","author":"C Grootaert","year":"2012","unstructured":"Grootaert C, Van de Wiele T, Verstraete W, Bracke M, Vanhoecke B. Angiopoietin-like protein 4: health effects, modulating agents and structure-function relationships. Expert Rev Proteomics. 2012;9:181\u201399.","journal-title":"Expert Rev Proteomics"},{"key":"7001_CR23","doi-asserted-by":"crossref","first-page":"15747","DOI":"10.1074\/jbc.M110.217638","volume":"286","author":"X Lei","year":"2011","unstructured":"Lei X, Shi F, Basu D, Huq A, Routhier S, Day R, et al. Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity. J Biol Chem. 2011;286:15747\u201356.","journal-title":"J Biol Chem"},{"key":"7001_CR24","doi-asserted-by":"crossref","first-page":"150272","DOI":"10.1098\/rsob.150272","volume":"6","author":"R Zhang","year":"2016","unstructured":"Zhang R. The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking. Open Biol. 2016;6:150272.","journal-title":"Open Biol"},{"key":"7001_CR25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1017\/S0007114507882961","volume":"100","author":"S Dutton","year":"2008","unstructured":"Dutton S, Trayhurn P. Regulation of angiopoietin-like protein 4\/fasting-induced adipose factor (Angptl4\/FIAF) expression in mouse white adipose tissue and 3T3-L1 adipocytes. Br J Nutr. 2008;100:18\u201326.","journal-title":"Br J Nutr"},{"key":"7001_CR26","doi-asserted-by":"crossref","first-page":"28488","DOI":"10.1074\/jbc.M004029200","volume":"275","author":"S Kersten","year":"2000","unstructured":"Kersten S, Mandard S, Tan NS, Escher P, Metzger D, Chambon P, et al. Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J Biol Chem. 2000;275:28488\u201393.","journal-title":"J Biol Chem"},{"key":"7001_CR27","doi-asserted-by":"crossref","first-page":"E1043","DOI":"10.1073\/pnas.1400889111","volume":"111","author":"M Catoire","year":"2014","unstructured":"Catoire M, Alex S, Paraskevopulos N, Mattijssen F, Evers-van Gogh I, Schaart G, et al. Fatty acid-inducible ANGPTL4 governs lipid metabolic response to exercise. Proc Natl Acad Sci U S A. 2014;111:E1043\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7001_CR28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1677\/JOE-07-0158","volume":"194","author":"T Josephs","year":"2007","unstructured":"Josephs T, Waugh H, Kokay I, Grattan D, Thompson M. Fasting-induced adipose factor identified as a key adipokine that is up-regulated in white adipose tissue during pregnancy and lactation in the rat. J Endocrinol. 2007;194:305\u201312.","journal-title":"J Endocrinol"},{"key":"7001_CR29","doi-asserted-by":"crossref","first-page":"34411","DOI":"10.1074\/jbc.M403058200","volume":"279","author":"S Mandard","year":"2004","unstructured":"Mandard S, Zandbergen F, Tan NS, Escher P, Patsouris D, Koenig W, et al. The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF\/PGAR\/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J Biol Chem. 2004;279:34411\u201320.","journal-title":"J Biol Chem"},{"key":"7001_CR30","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1006\/jmcc.2002.2021","volume":"34","author":"AJ Belanger","year":"2002","unstructured":"Belanger AJ, Lu H, Date T, Liu LX, Vincent KA, Akita GY, et al. Hypoxia up-regulates expression of peroxisome proliferator-activated receptor gamma angiopoietin-related gene (PGAR) in cardiomyocytes: role of hypoxia inducible factor 1alpha. J Mol Cell Cardiol. 2002;34:765\u201374.","journal-title":"J Mol Cell Cardiol"},{"key":"7001_CR31","doi-asserted-by":"crossref","first-page":"25593","DOI":"10.1074\/jbc.M109.025452","volume":"284","author":"SK Koliwad","year":"2009","unstructured":"Koliwad SK, Kuo T, Shipp LE, Gray NE, Backhed F, So AY, et al. Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism. J Biol Chem. 2009;284:25593\u2013601.","journal-title":"J Biol Chem"},{"key":"7001_CR32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1194\/jlr.M200367-JLR200","volume":"44","author":"R Kaplan","year":"2003","unstructured":"Kaplan R, Zhang T, Hernandez M, Gan FX, Wright SD, Waters MG, et al. Regulation of the angiopoietin-like protein 3 gene by LXR. J Lipid Res. 2003;44:136\u201343.","journal-title":"J Lipid Res"},{"key":"7001_CR33","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/ng.3561","volume":"48","author":"A Helgadottir","year":"2016","unstructured":"Helgadottir A, Gretarsdottir S, Thorleifsson G, Hjartarson E, Sigurdsson A, Magnusdottir A, et al. Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease. Nat Genet. 2016;48:634\u20139.","journal-title":"Nat Genet"},{"key":"7001_CR34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12944-016-0231-6","volume":"15","author":"K Abid","year":"2016","unstructured":"Abid K, Trimeche T, Mili D, Msolli MA, Trabelsi I, Nouira S, et al. ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels and predicts cardiovascular disease risk in type 2 diabetic Tunisian population. Lipids Health Dis. 2016;15:63.","journal-title":"Lipids Health Dis"},{"key":"7001_CR35","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/ATVBAHA.110.212209","volume":"30","author":"MC Smart-Halajko","year":"2010","unstructured":"Smart-Halajko MC, Robciuc MR, Cooper JA, Jauhiainen M, Kumari M, Kivimaki M, et al. The relationship between plasma angiopoietin-like protein 4 levels, angiopoietin-like protein 4 genotype, and coronary heart disease risk. Arterioscler Thromb Vasc Biol. 2010;30:2277\u201382.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7001_CR36","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.metabol.2007.12.007","volume":"57","author":"H Staiger","year":"2008","unstructured":"Staiger H, Machicao F, Werner R, Guirguis A, Weisser M, Stefan N, et al. Genetic variation within the ANGPTL4 gene is not associated with metabolic traits in white subjects at an increased risk for type 2 diabetes mellitus. Metabolism. 2008;57:637\u201343.","journal-title":"Metabolism."},{"key":"7001_CR37","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1161\/ATVBAHA.108.176917","volume":"28","author":"PJ Talmud","year":"2008","unstructured":"Talmud PJ, Smart M, Presswood E, Cooper JA, Nicaud V, Drenos F, et al. ANGPTL4 E40K and T266M: effects on plasma triglyceride and HDL levels, postprandial responses, and CHD risk. Arterioscler Thromb Vasc Biol. 2008;28:2319\u201325.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7001_CR38","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/ATVBAHA.107.151894","volume":"27","author":"L Lichtenstein","year":"2007","unstructured":"Lichtenstein L, Berbee JF, van Dijk SJ, van Dijk KW, Bensadoun A, Kema IP, et al. Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HL-dependent hepatic cholesterol uptake. Arterioscler Thromb Vasc Biol. 2007;27:2420\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7001_CR39","doi-asserted-by":"crossref","first-page":"28524","DOI":"10.1074\/jbc.M113.497602","volume":"288","author":"MJ Lafferty","year":"2013","unstructured":"Lafferty MJ, Bradford KC, Erie DA, Neher SB. Angiopoietin-like protein 4 inhibition of lipoprotein lipase: evidence for reversible complex formation. J Biol Chem. 2013;288:28524\u201334.","journal-title":"J Biol Chem"},{"key":"7001_CR40","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1073\/pnas.1900983116","volume":"116","author":"AP Beigneux","year":"2019","unstructured":"Beigneux AP, Allan CM, Sandoval NP, Cho GW, Heizer PJ, Jung RS, et al. Lipoprotein lipase is active as a monomer. Proc Natl Acad Sci U S A. 2019;116:6319\u201328.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7001_CR41","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1194\/jlr.M067363","volume":"57","author":"W Dijk","year":"2016","unstructured":"Dijk W, Beigneux AP, Larsson M, Bensadoun A, Young SG, Kersten S. Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes. J Lipid Res. 2016;57:1670\u201383.","journal-title":"J Lipid Res"},{"key":"7001_CR42","doi-asserted-by":"crossref","first-page":"14134","DOI":"10.1074\/jbc.RA118.002426","volume":"293","author":"W Dijk","year":"2018","unstructured":"Dijk W, Ruppert PMM, Oost LJ, Kersten S. Angiopoietin-like 4 promotes the intracellular cleavage of lipoprotein lipase by PCSK3\/furin in adipocytes. J Biol Chem. 2018;293:14134\u201345.","journal-title":"J Biol Chem"},{"key":"7001_CR43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cmet.2010.04.016","volume":"12","author":"BS Davies","year":"2010","unstructured":"Davies BS, Beigneux AP, Barnes RH 2nd, Tu Y, Gin P, Weinstein MM, et al. GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries. Cell Metab. 2010;12:42\u201352.","journal-title":"Cell Metab"},{"key":"7001_CR44","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1194\/jlr.M900145-JLR200","volume":"50","author":"WK Sonnenburg","year":"2009","unstructured":"Sonnenburg WK, Yu D, Lee EC, Xiong W, Gololobov G, Key B, et al. GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4. J Lipid Res. 2009;50:2421\u20139.","journal-title":"J Lipid Res"},{"key":"7001_CR45","doi-asserted-by":"crossref","unstructured":"Mysling S, Kristensen KK, Larsson M, Kovrov O, Bensadouen A, Jorgensen TJ, et al. The angiopoietin-like protein ANGPTL4 catalyzes unfolding of the hydrolase domain in lipoprotein lipase and the endothelial membrane protein GPIHBP1 counteracts this unfolding. Elife. 2016;5.","DOI":"10.7554\/eLife.20958"},{"key":"7001_CR46","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cmet.2007.02.002","volume":"5","author":"AP Beigneux","year":"2007","unstructured":"Beigneux AP, Davies BS, Gin P, Weinstein MM, Farber E, Qiao X, et al. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab. 2007;5:279\u201391.","journal-title":"Cell Metab"},{"issue":"Suppl","key":"7001_CR47","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1194\/jlr.R800030-JLR200","volume":"50","author":"AP Beigneux","year":"2009","unstructured":"Beigneux AP, Davies BS, Bensadoun A, Fong LG, Young SG. GPIHBP1, a GPI-anchored protein required for the lipolytic processing of triglyceride-rich lipoproteins. J Lipid Res. 2009;50(Suppl):S57\u201362.","journal-title":"J Lipid Res"},{"key":"7001_CR48","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrendo.2017.119","volume":"13","author":"S Kersten","year":"2017","unstructured":"Kersten S. Angiopoietin-like 3 in lipoprotein metabolism. Nat Rev Endocrinol. 2017;13:731\u20139.","journal-title":"Nat Rev Endocrinol"},{"key":"7001_CR49","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.molmet.2017.06.014","volume":"6","author":"X Chi","year":"2017","unstructured":"Chi X, Britt EC, Shows HW, Hjelmaas AJ, Shetty SK, Cushing EM, et al. ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase. Mol Metab. 2017;6:1137\u201349.","journal-title":"Mol Metab."},{"key":"7001_CR50","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1194\/jlr.M075689","volume":"58","author":"JF Haller","year":"2017","unstructured":"Haller JF, Mintah IJ, Shihanian LM, Stevis P, Buckler D, Alexa-Braun CA, et al. ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance. J Lipid Res. 2017;58:1166\u201373.","journal-title":"J Lipid Res"},{"key":"7001_CR51","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1194\/jlr.M500005-JLR200","volume":"46","author":"H Ge","year":"2005","unstructured":"Ge H, Cha JY, Gopal H, Harp C, Yu X, Repa JJ, et al. Differential regulation and properties of angiopoietin-like proteins 3 and 4. J Lipid Res. 2005;46:1484\u201390.","journal-title":"J Lipid Res"},{"key":"7001_CR52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00011-013-0678-0","volume":"63","author":"L Guo","year":"2014","unstructured":"Guo L, Li SY, Ji FY, Zhao YF, Zhong Y, Lv XJ, et al. Role of Angptl4 in vascular permeability and inflammation. Inflamm Res. 2014;63:13\u201322.","journal-title":"Inflamm Res"},{"key":"7001_CR53","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00109-002-0384-9","volume":"80","author":"JR Mead","year":"2002","unstructured":"Mead JR, Irvine SA, Ramji DP. Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med (Berl). 2002;80:753\u201369.","journal-title":"J Mol Med (Berl)"},{"key":"7001_CR54","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1194\/jlr.C200010-JLR200","volume":"43","author":"K Yoshida","year":"2002","unstructured":"Yoshida K, Shimizugawa T, Ono M, Furukawa H. Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J Lipid Res. 2002;43:1770\u20132.","journal-title":"J Lipid Res"},{"key":"7001_CR55","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1074\/jbc.M506519200","volume":"281","author":"S Mandard","year":"2006","unstructured":"Mandard S, Zandbergen F, van Straten E, Wahli W, Kuipers F, Muller M, et al. The fasting-induced adipose factor\/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem. 2006;281:934\u201344.","journal-title":"J Biol Chem"},{"key":"7001_CR56","doi-asserted-by":"crossref","unstructured":"Aryal B, Singh AK, Zhang X, Varela L, Rotllan N, Goedeke L, et al. Absence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis. JCI Insight. 2018;3.","DOI":"10.1172\/jci.insight.97918"},{"key":"7001_CR57","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.molmet.2018.03.011","volume":"11","author":"AK Singh","year":"2018","unstructured":"Singh AK, Aryal B, Chaube B, Rotllan N, Varela L, Horvath TL, et al. Brown adipose tissue derived ANGPTL4 controls glucose and lipid metabolism and regulates thermogenesis. Mol Metab. 2018;11:59\u201369.","journal-title":"Mol Metab."},{"key":"7001_CR58","doi-asserted-by":"crossref","unstructured":"Dijk W, Heine M, Vergnes L, Boon MR, Schaart G, Hesselink MK, et al. ANGPTL4 mediates shuttling of lipid fuel to brown adipose tissue during sustained cold exposure. Elife. 2015;4.","DOI":"10.7554\/eLife.08428"},{"key":"7001_CR59","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0022-2275(20)38369-3","volume":"30","author":"CF Semenkovich","year":"1989","unstructured":"Semenkovich CF, Chen SH, Wims M, Luo CC, Li WH, Chan L. Lipoprotein lipase and hepatic lipase mRNA tissue specific expression, developmental regulation, and evolution. J Lipid Res. 1989;30:423\u201331.","journal-title":"J Lipid Res"},{"key":"7001_CR60","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1210\/en.2005-0476","volume":"146","author":"A Koster","year":"2005","unstructured":"Koster A, Chao YB, Mosior M, Ford A, Gonzalez-DeWhitt PA, Hale JE, et al. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology. 2005;146:4943\u201350.","journal-title":"Endocrinology"},{"key":"7001_CR61","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/CIRCRESAHA.110.217380","volume":"106","author":"A Georgiadi","year":"2010","unstructured":"Georgiadi A, Lichtenstein L, Degenhardt T, Boekschoten MV, van Bilsen M, Desvergne B, et al. Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta\/delta and protects against fatty acid-induced oxidative stress. Circ Res. 2010;106:1712\u201321.","journal-title":"Circ Res"},{"key":"7001_CR62","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1073\/pnas.0409564102","volume":"102","author":"X Yu","year":"2005","unstructured":"Yu X, Burgess SC, Ge H, Wong KK, Nassem RH, Garry DJ, et al. Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart. Proc Natl Acad Sci U S A. 2005;102:1767\u201372.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7001_CR63","doi-asserted-by":"crossref","first-page":"E246","DOI":"10.1152\/ajpendo.00211.2004","volume":"288","author":"D An","year":"2005","unstructured":"An D, Pulinilkunnil T, Qi D, Ghosh S, Abrahani A, Rodrigues B. The metabolic \"switch\" AMPK regulates cardiac heparin-releasable lipoprotein lipase. Am J Physiol Endocrinol Metab. 2005;288:E246\u201353.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"7001_CR64","doi-asserted-by":"crossref","first-page":"e46212","DOI":"10.1371\/journal.pone.0046212","volume":"7","author":"MR Robciuc","year":"2012","unstructured":"Robciuc MR, Skrobuk P, Anisimov A, Olkkonen VM, Alitalo K, Eckel RH, et al. Angiopoietin-like 4 mediates PPAR delta effect on lipoprotein lipase-dependent fatty acid uptake but not on beta-oxidation in myotubes. PLoS One. 2012;7:e46212.","journal-title":"PLoS One"},{"key":"7001_CR65","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2337\/db07-1438","volume":"58","author":"H Staiger","year":"2009","unstructured":"Staiger H, Haas C, Machann J, Werner R, Weisser M, Schick F, et al. Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans. Diabetes. 2009;58:579\u201389.","journal-title":"Diabetes."},{"key":"7001_CR66","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1124\/mol.59.2.170","volume":"59","author":"PJ Davies","year":"2001","unstructured":"Davies PJ, Berry SA, Shipley GL, Eckel RH, Hennuyer N, Crombie DL, et al. Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activity. Mol Pharmacol. 2001;59:170\u20136.","journal-title":"Mol Pharmacol"},{"key":"7001_CR67","first-page":"E229","volume":"268","author":"RL Seip","year":"1995","unstructured":"Seip RL, Angelopoulos TJ, Semenkovich CF. Exercise induces human lipoprotein lipase gene expression in skeletal muscle but not adipose tissue. Am J Phys. 1995;268:E229\u201336.","journal-title":"Am J Phys"},{"key":"7001_CR68","first-page":"E255","volume":"272","author":"RL Seip","year":"1997","unstructured":"Seip RL, Mair K, Cole TG, Semenkovich CF. Induction of human skeletal muscle lipoprotein lipase gene expression by short-term exercise is transient. Am J Phys. 1997;272:E255\u201361.","journal-title":"Am J Phys"},{"key":"7001_CR69","doi-asserted-by":"crossref","first-page":"e51066","DOI":"10.1371\/journal.pone.0051066","volume":"7","author":"M Catoire","year":"2012","unstructured":"Catoire M, Mensink M, Boekschoten MV, Hangelbroek R, Muller M, Schrauwen P, et al. Pronounced effects of acute endurance exercise on gene expression in resting and exercising human skeletal muscle. PLoS One. 2012;7:e51066.","journal-title":"PLoS One"},{"key":"7001_CR70","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1113\/jphysiol.2008.166512","volume":"587","author":"DM Thomson","year":"2009","unstructured":"Thomson DM, Brown JD, Fillmore N, Ellsworth SK, Jacobs DL, Winder WW, et al. AMP-activated protein kinase response to contractions and treatment with the AMPK activator AICAR in young adult and old skeletal muscle. J Physiol. 2009;587:2077\u201386.","journal-title":"J Physiol"},{"key":"7001_CR71","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.molmet.2013.11.004","volume":"3","author":"F Mattijssen","year":"2014","unstructured":"Mattijssen F, Alex S, Swarts HJ, Groen AK, van Schothorst EM, Kersten S. Angptl4 serves as an endogenous inhibitor of intestinal lipid digestion. Mol Metab. 2014;3:135\u201344.","journal-title":"Mol Metab"},{"key":"7001_CR72","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1128\/MCB.00858-12","volume":"33","author":"S Alex","year":"2013","unstructured":"Alex S, Lange K, Amolo T, Grinstead JS, Haakonsson AK, Szalowska E, et al. Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor gamma. Mol Cell Biol. 2013;33:1303\u201316.","journal-title":"Mol Cell Biol"},{"key":"7001_CR73","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","volume":"101","author":"F Backhed","year":"2004","unstructured":"Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004;101:15718\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7001_CR74","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature11552","volume":"489","author":"V Tremaroli","year":"2012","unstructured":"Tremaroli V, Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012;489:242\u20139.","journal-title":"Nature."},{"key":"7001_CR75","doi-asserted-by":"crossref","first-page":"G1025","DOI":"10.1152\/ajpgi.00293.2012","volume":"304","author":"A Korecka","year":"2013","unstructured":"Korecka A, de Wouters T, Cultrone A, Lapaque N, Pettersson S, Dore J, et al. ANGPTL4 expression induced by butyrate and rosiglitazone in human intestinal epithelial cells utilizes independent pathways. Am J Physiol Gastrointest Liver Physiol. 2013;304:G1025\u201337.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"7001_CR76","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1073\/pnas.0605374104","volume":"104","author":"F Backhed","year":"2007","unstructured":"Backhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A. 2007;104:979\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7001_CR77","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.bbrc.2008.12.018","volume":"379","author":"H Adachi","year":"2009","unstructured":"Adachi H, Fujiwara Y, Kondo T, Nishikawa T, Ogawa R, Matsumura T, et al. Angptl 4 deficiency improves lipid metabolism, suppresses foam cell formation and protects against atherosclerosis. Biochem Biophys Res Commun. 2009;379:806\u201311.","journal-title":"Biochem Biophys Res Commun"},{"key":"7001_CR78","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ng.2795","volume":"45","author":"R Do","year":"2013","unstructured":"Do R, Willer CJ, Schmidt EM, Sengupta S, Gao C, Peloso GM, et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet. 2013;45:1345\u201352.","journal-title":"Nat Genet"},{"key":"7001_CR79","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1161\/ATVBAHA.113.301698","volume":"33","author":"A Georgiadi","year":"2013","unstructured":"Georgiadi A, Wang Y, Stienstra R, Tjeerdema N, Janssen A, Stalenhoef A, et al. Overexpression of angiopoietin-like protein 4 protects against atherosclerosis development. Arterioscler Thromb Vasc Biol. 2013;33:1529\u201337.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7001_CR80","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbrc.2012.07.048","volume":"425","author":"E Makoveichuk","year":"2012","unstructured":"Makoveichuk E, Sukonina V, Kroupa O, Thulin P, Ehrenborg E, Olivecrona T, et al. Inactivation of lipoprotein lipase occurs on the surface of THP-1 macrophages where oligomers of angiopoietin-like protein 4 are formed. Biochem Biophys Res Commun. 2012;425:138\u201343.","journal-title":"Biochem Biophys Res Commun"},{"key":"7001_CR81","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","volume":"145","author":"KJ Moore","year":"2011","unstructured":"Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145:341\u201355.","journal-title":"Cell."},{"key":"7001_CR82","doi-asserted-by":"crossref","first-page":"20180147","DOI":"10.1098\/rstb.2018.0147","volume":"374","author":"SA Doodnauth","year":"2019","unstructured":"Doodnauth SA, Grinstein S, Maxson ME. Constitutive and stimulated macropinocytosis in macrophages: roles in immunity and in the pathogenesis of atherosclerosis. Philos Trans R Soc Lond Ser B Biol Sci. 2019;374:20180147.","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"7001_CR83","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cmet.2010.11.002","volume":"12","author":"L Lichtenstein","year":"2010","unstructured":"Lichtenstein L, Mattijssen F, de Wit NJ, Georgiadi A, Hooiveld GJ, van der Meer R, et al. Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages. Cell Metab. 2010;12:580\u201392.","journal-title":"Cell Metab"},{"key":"7001_CR84","doi-asserted-by":"crossref","first-page":"12313","DOI":"10.1038\/ncomms12313","volume":"7","author":"B Aryal","year":"2016","unstructured":"Aryal B, Rotllan N, Araldi E, Ramirez CM, He S, Chousterman BG, et al. ANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and atherosclerosis progression. Nat Commun. 2016;7:12313.","journal-title":"Nat Commun"},{"key":"7001_CR85","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1749-6632.1990.tb42279.x","volume":"598","author":"MA Gimbrone Jr","year":"1990","unstructured":"Gimbrone MA Jr, Bevilacqua MP, Cybulsky MI. Endothelial-dependent mechanisms of leukocyte adhesion in inflammation and atherosclerosis. Ann N Y Acad Sci. 1990;598:77\u201385.","journal-title":"Ann N Y Acad Sci"},{"key":"7001_CR86","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/08916930903002529","volume":"42","author":"G Foteinos","year":"2009","unstructured":"Foteinos G, Xu Q. Immune-mediated mechanisms of endothelial damage in atherosclerosis. Autoimmunity. 2009;42:627\u201333.","journal-title":"Autoimmunity."},{"key":"7001_CR87","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/hep.24479","volume":"54","author":"H Li","year":"2011","unstructured":"Li H, Ge C, Zhao F, Yan M, Hu C, Jia D, et al. Hypoxia-inducible factor 1 alpha-activated angiopoietin-like protein 4 contributes to tumor metastasis via vascular cell adhesion molecule-1\/integrin beta1 signaling in human hepatocellular carcinoma. Hepatology. 2011;54:910\u20139.","journal-title":"Hepatology."},{"key":"7001_CR88","doi-asserted-by":"crossref","first-page":"18721","DOI":"10.1073\/pnas.0609025103","volume":"103","author":"A Galaup","year":"2006","unstructured":"Galaup A, Cazes A, Le Jan S, Philippe J, Connault E, Le Coz E, et al. Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc Natl Acad Sci U S A. 2006;103:18721\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7001_CR89","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1182\/blood-2011-01-328716","volume":"118","author":"RL Huang","year":"2011","unstructured":"Huang RL, Teo Z, Chong HC, Zhu P, Tan MJ, Tan CK, et al. ANGPTL4 modulates vascular junction integrity by integrin signaling and disruption of intercellular VE-cadherin and claudin-5 clusters. Blood. 2011;118:3990\u20134002.","journal-title":"Blood."},{"key":"7001_CR90","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/01.ATV.0000249683.80414.d9","volume":"27","author":"J Wang","year":"2007","unstructured":"Wang J, Xian X, Huang W, Chen L, Wu L, Zhu Y, et al. Expression of LPL in endothelial-intact artery results in lipid deposition and vascular cell adhesion molecule-1 upregulation in both LPL and ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 2007;27:197\u2013203.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7001_CR91","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.jacc.2017.02.030","volume":"69","author":"NO Stitziel","year":"2017","unstructured":"Stitziel NO, Khera AV, Wang X, Bierhals AJ, Vourakis AC, Sperry AE, et al. ANGPTL3 deficiency and protection against coronary artery disease. J Am Coll Cardiol. 2017;69:2054\u201363.","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-020-07001-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-020-07001-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-020-07001-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T15:36:40Z","timestamp":1666798600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-020-07001-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,4]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["7001"],"URL":"https:\/\/doi.org\/10.1007\/s10557-020-07001-0","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,4]]},"assertion":[{"value":"4 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"There are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}